Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

RPTX Repare Therapeutics Inc

1,27

0,07 (5,83%)

15 Feb 2025 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

Repare Therapeutics (NASDAQ:RPTX)
Historical Stock Chart
Von Jan 2025 bis Feb 2025

Click Here for more Repare Therapeutics Charts.

Repare Therapeutics (NASDAQ:RPTX)
Historical Stock Chart
Von Feb 2024 bis Feb 2025

Click Here for more Repare Therapeutics Charts.

News Repare Therapeutics Inc

Form 8-K - Current report
Freitag 10 Januar 2025 (1 Monat vor) • Edgar (US Regulatory)

Repare Therapeutics Announces Portfolio Re-Prioritization, Partnering Initiatives and Cost Reductions
Donnerstag 9 Januar 2025 (1 Monat vor) • Business Wire

Form 8-K - Current report
Donnerstag 12 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial
Donnerstag 12 Dezember 2024 (2 Monate vor) • Business Wire

Repare Therapeutics to Host Webcast to Report Data from the Lunresertib and Camonsertib Combination Phase 1 MYTHIC Clinical Trial
Dienstag 10 Dezember 2024 (2 Monate vor) • Business Wire

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Repare Therapeutics Announces Agreement with the US National Cancer Institute to Advance the Development of Camonsertib
Dienstag 12 November 2024 (3 Monate vor) • Business Wire

Form 424B5 - Prospectus [Rule 424(b)(5)]
Donnerstag 7 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 7 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 7 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Repare Therapeutics Provides Business and Clinical Update and Reports Third Quarter 2024 Financial Results
Donnerstag 7 November 2024 (3 Monate vor) • Business Wire

Weitere Repare Therapeutics Inc News-Artikel

Gold vs US Dollar

Invesco QQQ Trust Series 1

Deutsche Telekom (QX)

Deutsche Telekom

Energy Select Sector SPDR

Euro vs Sterling

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen